Clinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer

被引：0
|
作者：
Christopoulos, P. [1 ]
Kohlhaeufl, J. [1 ]
Bozorgmehr, F. [1 ]
Kuon, J. [1 ]
Schneider, M. [1 ]
Neumann, O. [1 ]
Liersch, S. [1 ]
Heussel, C. [1 ]
Winter, H. [1 ]
Herth, F. [1 ]
Rieken, S. [2 ]
Muley, T. [1 ]
Meister, M. [1 ]
Bischoff, H. [1 ]
Lasitschka, F. [1 ]
Stenzinger, A. [3 ]
Thomas, M. [1 ]
机构：
[1] Thoraxklin Heidelberg, Oncol, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10P
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [12] The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Hu, Da-Hai
    Wong, Wan-Ching
    Zhou, Jia-Xin
    Luo, Ji
    Cai, Song-Wang
    Zhou, Hong
    Tang, Hui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [13] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [14] Effect of antibiotic treatment on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer
    Alkan, G.
    Oztas, N. Senturk
    Turna, Z. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1082 - S1082
  • [15] Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer
    Wang, Xinan
    Ricciuti, Biagio
    Alessi, Joao, V
    Nguyen, Tom
    Awad, Mark M.
    Lin, Xihong
    Johnson, Bruce E.
    Christiani, David C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (12): : 1761 - 1769
  • [16] Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
    Ou Yamaguchi
    Hisao Imai
    Hiroyuki Minemura
    Kensuke Suzuki
    Satoshi Wasamoto
    Yukihiro Umeda
    Takashi Osaki
    Norimitsu Kasahara
    Junji Uchino
    Tomohide Sugiyama
    Shinichi Ishihara
    Hisashi Ishii
    Ichiro Naruse
    Keita Mori
    Mie Kotake
    Kenya Kanazawa
    Koichi Minato
    Hiroshi Kagamu
    Kyoichi Kaira
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 761 - 771
  • [17] Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
    Yamaguchi, Ou
    Imai, Hisao
    Minemura, Hiroyuki
    Suzuki, Kensuke
    Wasamoto, Satoshi
    Umeda, Yukihiro
    Osaki, Takashi
    Kasahara, Norimitsu
    Uchino, Junji
    Sugiyama, Tomohide
    Ishihara, Shinichi
    Ishii, Hisashi
    Naruse, Ichiro
    Mori, Keita
    Kotake, Mie
    Kanazawa, Kenya
    Minato, Koichi
    Kagamu, Hiroshi
    Kaira, Kyoichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 761 - 771
  • [18] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    Scientific Reports, 14
  • [19] A CASE OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS IN NON-SMALL CELL LUNG CANCER
    Murphy, Andrew
    Ismail, Ali
    Monzer, Nasser
    Sangoi, Matthew
    Khan, Aarish Husain
    Khazan, Benjamin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 3191 - 3191
  • [20] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
12345